Net income 2018
Net cash position 2018
P/E ratio 2018
Net income 2019
Net cash position 2019
P/E ratio 2019
1 849 M
1 849 M
EV / Sales 2018
EV / Sales 2019
Nbr of Employees
Akcea Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. The Company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. (Ionis). The Company's volanesorsen drug...
Notations Surperformance© of Akcea Therapeutics, Inc.
Trading Rating :
Investor Rating :
All news about AKCEA THERAPEUTICS, INC.
11/10 IONIS PHARMACEUTICALS : Akcea Therapeutics - WAYLIVRA, the first and only therap..
11/09 IONIS PHARMACEUTICALS : and Akcea Recognize FCS Awareness Day with Global Commun..
11/04 IONIS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
11/04 Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study ..
11/02 IONIS PHARMACEUTICALS : and Akcea win prestigious Prix Galien Award for TEGSEDI ..
10/13 IONIS PHARMACEUTICALS : completes acquisition of Akcea Therapeutics
10/13 AKCEA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Notice of..
10/13 IONIS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, ..
10/12 AKCEA THERAPEUTICS : Ionis Pharmaceuticals completes acquisition of Akcea Therap..
09/18 AKCEA THERAPEUTICS : WAYLIVRA▼® (volanesorsen), the First and Only Therapy..
09/11 WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigati..
09/05 KASKELA LAW LLC : Announces Stockholder Investigation of Akcea Therapeutics, Inc..
09/04 AKCEA INVESTOR ALERT BY THE FORMER A : Kahn Swick & Foti, LLC Investigates Adequ..
09/01 Monteverde & Associates PC Announces an Investigation of Akcea Therapeutics, ..
08/31 AKCEA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Amendment..
News in other languages on AKCEA THERAPEUTICS, INC.
Chart AKCEA THERAPEUTICS, INC.